In 2018, SGC successfully obtained Grants from the Government of Hong Kong by a close collaboration with the Hong Kong University of Science & Technology(UST). (Project Reference: UIM/340) A successful biotechnology industry must be evolved gradually to the present shape as led by a matrix of factors including Government support, the territory’s research and technology prowess, market forces and source of capitals. In the face of global competition, SGC is leveraging on the opportunities arising from the increasing Government concern on innovative biotechnology. SGC has successfully been the PIONEER & the only anti-aging and aesthetic project funded by the Government of Hong Kong, this endorsement delivered a meaningful message: innovative, natural and safe.
SGC, a local developed biomedical product on skin rejuvenation and anti-aging, is in a category of high value-added industry. It can take advantage of many favourable conditions in Hong Kong: International image, strict regulations, well developed infrastructure and communication, geographically closed by China nourished with large population of consuming power.
Under the University-Industry Collaboration Programme, a substantial contribution and participation from the UST to SGC will be expected by the Government. The University’s researchers are required to be the core project team members and conduct a major part of the R&D work of the project. Intellectual Property Rights arising from the project will be solely owned by our company. The added value, productivity and competitiveness will path SGC the way to success on innovation and technology upgrading in biotechnology industry for the coming 10 years.
The UST has contributed its greatest effort in the application. The strict regulations and a controversial topic of handling human substances in HK made the application complicated and sophisticated. Having a strict supervision, the safety and ethics of SGC study has been guaranteed by the Safety Panel of the University.
SGC well understood that excellence in scientific frontiers with continuous research breakthroughs remains a key determinant in fueling development of acompetitive biotechnology industry. As UST research and education enjoys a good reputation and ranked among the best in the world, an affirmative support from the Government and investors through leveraging the knowledge and resources from the University in the coming ten years. We believe both subjects have far-reaching implications to the sustainable growth of SGC!